IP Library › Granted Patent US 10,527,609
Granted Patent B2
US 10,527,609 · App. 16/274,908 · Granted Jan 7, 2020

Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds

Inventor: Mark Howarth (Oxford, GB)
Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
G01N33/531C07K7/08C07K14/315G01N33/5306C07K2319/21C07K2319/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,527,609
App. No.
16/274,908
Granted
Jan 7, 2020
Kind
B2
Abstract

Described herein is a protein capable of spontaneously forming an isopeptide bond for the development of a peptide tag and binding partner pair wherein the peptide tag and binding partner are capable of covalently binding to each other via an isopeptide bond. Also provided is a method for developing a peptide tag and binding partner pair which are capable of covalently binding to each other based on a protein which is capable of spontaneously forming an isopeptide bond. Additionally provided are peptide tag and binding partner pairs which are obtainable from isopeptide proteins. Further, specifically developed peptide tags and binding partners are described, together with nucleic acid molecules and vectors which encode those peptides or proteins.

Claims (10)

1. A peptide tag comprising a fragment of an isopeptide protein selected from the group consisting of:

(i) FbaB from Streptococcus pyogenes as set forth in SEQ ID NO:6, or a protein with at least 80% identity thereto capable of spontaneously forming an isopeptide bond; and

(ii) major pilin protein Spy0128 from Streptococcus pyogenes as set forth in SEQ ID NO:1, or a protein with at least 95% identity thereto capable of spontaneously forming an isopeptide bond,

wherein said fragment has a length of at least 5 amino acids but no more than 50 amino acids and comprises a reactive residue involved in said isopeptide bond in said isopeptide protein and is capable of binding to a peptide binding partner by forming an isopeptide bond between said reactive residue and a reactive residue in said peptide binding partner, wherein said peptide binding partner is at least 20 amino acids in length and comprises:

(a) a fragment of the isopeptide protein of (i) wherein a lysine is present at a position that corresponds to position 15 of SEQ ID NO:6; or

(b) a fragment of the isopeptide protein of (ii) comprising residues 31-291 of the sequence set out in SEQ ID NO:1,

wherein said peptide tag is conjugated to a nucleic acid molecule, protein, peptide, antibody, small-molecule organic compound, fluorophore, metal-ligand complex, polysaccharide, nanoparticle, nanotube, polymer or a combination thereof.

2. The peptide tag of claim 1 , wherein said peptide tag comprises a fragment of an isopeptide protein of a sequence with at least 80% identity to SEQ ID NO: 6, wherein an aspartic acid is present at a position corresponding to position 101 of SEQ ID NO:6, and wherein said peptide tag is capable of binding to a peptide binding partner by forming an isopeptide bond between said aspartic acid residue and a lysine residue in said peptide binding partner, wherein said peptide binding partner is at least 20 amino acids in length and comprises a fragment of the isopeptide protein of (i) wherein a lysine is present at a position that corresponds to position 15 of SEQ ID NO:6.

3. The peptide tag of claim 1 , wherein said peptide tag comprises a fragment of an isopeptide protein of a sequence with at least 90% identity to SEQ ID NO: 6, wherein an aspartic acid is present at a position corresponding to position 101 of SEQ ID NO:6, and wherein said peptide tag is capable of binding to a peptide binding partner by forming an isopeptide bond between said aspartic acid residue and a lysine residue in said peptide binding partner, wherein said peptide binding partner is at least 20 amino acids in length and comprises a fragment of the isopeptide protein of (i) wherein a lysine is present at a position that corresponds to position 15 of SEQ ID NO:6.

4. The peptide tag of claim 1 , wherein said peptide tag comprises a fragment of an isopeptide protein of a sequence with at least 95% identity to SEQ ID NO: 6, wherein an aspartic acid is present at a position corresponding to position 101 of SEQ ID NO:6, and wherein said peptide tag is capable of binding to a peptide binding partner by forming an isopeptide bond between said aspartic acid residue and a lysine residue in said peptide binding partner, wherein said peptide binding partner is at least 20 amino acids in length and comprises a fragment of the isopeptide protein of (i) wherein a lysine is present at a position that corresponds to position 15 of SEQ ID NO:6.

Priority Claims (1)
GB 1002362 · Feb 11, 2010 · national
Continuity (3)
Division 15359796 · Nov 23, 2016
Division 13578070
Related Publication 20190178878A1 · Jun 13, 2019